eSTI2 provides the capacity to work with commercial organisations in developing point of care sexual health assays, translating probes for commercial use and evaluating early stage diagnostics. eSTI2 is working with a number of commercial companies, providing assistance in their point of care diagnostic development, including assays for Chlamydia trachomatis, Neisseria gonorrhoeae, Micoplasma genitalium and Trichomonas vaginalis.

 

Partners that eSTI2 are currently working with include:-

 

    TwistDx Limited
    Healthcare Diagnostics
    Atlas Genetics
    QuantuMDx Group